CVS Health (NYSE:CVS) Issues FY 2020 Pre-Market Earnings Guidance

CVS Health (NYSE:CVS) updated its FY 2020
Pre-Market earnings guidance on Tuesday. The company provided EPS guidance of 7.14-7.27 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.23. CVS Health also updated its FY20 guidance to $7.14-7.27 EPS.

Several equities research analysts have commented on CVS shares. Credit Suisse Group boosted their price target on shares of CVS Health from $75.00 to $90.00 and gave the stock an outperform rating in a research report on Friday, August 7th. Royal Bank of Canada reiterated a buy rating on shares of CVS Health in a research report on Thursday, July 9th. SVB Leerink boosted their price target on shares of CVS Health from $72.00 to $73.00 and gave the stock a market perform rating in a research report on Thursday, August 6th. Finally, Deutsche Bank dropped their price target on shares of CVS Health from $109.00 to $104.00 and set a buy rating on the stock in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus target price of $82.60.

Shares of NYSE CVS opened at $57.97 on Tuesday. The stock has a market cap of $75.87 billion, a price-to-earnings ratio of 9.22, a PEG ratio of 1.42 and a beta of 0.67. The company has a debt-to-equity ratio of 0.93, a quick ratio of 0.72 and a current ratio of 0.98. The business has a 50 day simple moving average of $62.89 and a 200 day simple moving average of $62.41. CVS Health has a 52 week low of $52.04 and a 52 week high of $77.03.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.71. The firm had revenue of $65.30 billion during the quarter, compared to analysts’ expectations of $64.29 billion. CVS Health had a return on equity of 16.32% and a net margin of 3.13%. The company’s revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.89 earnings per share. On average, analysts predict that CVS Health will post 7.23 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Find a Trading Strategy That Works

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply